Weight loss drugmaker Novo Nordisk vies to become Europe's most valuable company, toppling LVMH
www.cnbc.com
Novo Nordisk overtook the Louis Vuitton owner's market capitalization as investors bet on the potential of its weight loss drugs.

Novo Nordisk overtook the Louis Vuitton owner’s market capitalization as investors bet on the potential of its weight loss drugs.